Oncofocus® Cancer Test and targeted therapies. The Revolution in cancer treatment has begun.
Chemotherapy is no longer the only option against cancer, there are now more than 600 targeted therapies available to treat solid tumours. Targeted therapies are the cornerstone of personalized medicine, a form of medicine that uses information about a person’s DNA...
Mutation-Targeted Therapy Slows Lung Cancer (NSCLC)
Patients with previously treated advanced non-small cell lung cancer (NSCLC) lived more than twice as long without disease progression when treated with a drug that targets a key resistance mutation versus standard chemotherapy, investigators reported. Treatment...
Lung Cancer Driver Discovery May Lead to Novel Therapy for Some Mesothelioma Patients
Lung adenocarcinoma, the most aggressive subtype of non-small cell lung cancer (NSCLC), comprises nearly 40 percent of lung cancer diagnoses. The KRAS gene is the most significant driver of this cancer, and is also found in some pleural mesothelioma cases....